Novo Nordisk and Eli Lilly shares both fall after Ozempic price-cut plan
Shares of Novo Nordisk and rival Eli Lilly fell on Tuesday after a report said price cuts are coming for popular weight-loss drugs.
📰 Original Source
Read full article at Marketwatch →KhanList aggregates and links to publicly available news content. We do not host full articles from third-party sources. Always verify important information with original sources.